Replies to post #131160 on Biotech Values

[mcbio]

If it is just comparable to Zytiga plus prednisone, I don't think MDV3100 automatically becomes SOC.

Yeah, perhaps not SOC, but I assume in such a scenario MDV3100 would still be a likely blockbuster.